This inventor holds 4 USPTO granted patents. Top assignees: Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gesellschaft MIT Beschraenkter Haftung. Active years: 1976-1980.
Company Filing History:
3 out of 1,248 
1 out of 100 Years Active: 1976-1980
Title: Helmut Muller-Calgan: Innovator in Central Nervous System Depressants
Introduction
Helmut Muller-Calgan is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of central nervous system depressants. With a total of 4 patents to his name, his work has had a considerable impact on medical science.
Latest Patents
Muller-Calgan's latest patents include innovative compounds such as 3-Fluorobenzodiazepines. These compounds are characterized by their unique formula, wherein R¹ can be hydrogen, alkyl, or fluorinated alkyl of 1-4 carbon atoms, and R² is phenyl, monohalophenyl, or pyridyl. Additionally, he has developed phenoxy heterocyclic amines, which are also significant in the realm of pharmaceuticals.
Career Highlights
Throughout his career, Muller-Calgan has worked with prominent organizations, including Merck Patent Gesellschaft mit beschränkter Haftung. His expertise in the field has allowed him to contribute to various innovative projects that enhance the understanding and treatment of central nervous system disorders.
Collaborations
Muller-Calgan has collaborated with esteemed colleagues such as Jurgen Uhl and Rochus Jonas. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Helmut Muller-Calgan's contributions to the field of pharmaceuticals, particularly in the development of central nervous system depressants, highlight his role as a significant inventor. His work continues to influence medical science and improve patient care.